These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 30064061)

  • 1. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
    Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug checking services at music festivals and events in a Canadian setting.
    McCrae K; Tobias S; Tupper K; Arredondo J; Henry B; Mema S; Wood E; Ti L
    Drug Alcohol Depend; 2019 Dec; 205():107589. PubMed ID: 31605958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting fentanyl using point-of-care drug checking technologies: A validation study.
    Ti L; Tobias S; Lysyshyn M; Laing R; Nosova E; Choi J; Arredondo J; McCrae K; Tupper K; Wood E
    Drug Alcohol Depend; 2020 Jul; 212():108006. PubMed ID: 32438280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
    Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
    Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA.
    Karch L; Tobias S; Schmidt C; Doe-Simkins M; Carter N; Salisbury-Afshar E; Carlberg-Racich S
    Drug Alcohol Depend; 2021 Nov; 228():108976. PubMed ID: 34536717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
    Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
    Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.
    Crepeault H; Socias ME; Tobias S; Lysyshyn M; Custance A; Shapiro A; Ti L
    Drug Alcohol Rev; 2023 Mar; 42(3):538-543. PubMed ID: 36423900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High willingness to use rapid fentanyl test strips among young adults who use drugs.
    Krieger MS; Yedinak JL; Buxton JA; Lysyshyn M; Bernstein E; Rich JD; Green TC; Hadland SE; Marshall BDL
    Harm Reduct J; 2018 Feb; 15(1):7. PubMed ID: 29422052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
    Tobias S; Ferguson M; Palis H; Burmeister C; McDougall J; Liu L; Graham B; Ti L; Buxton JA
    Int J Drug Policy; 2024 Jan; 123():104290. PubMed ID: 38101275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
    Lockwood TE; Vervoordt A; Lieberman M
    Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada.
    Kennedy MC; Dong H; Tobias S; Buxton JA; Lysyshyn M; Tupper KW; Ti L
    Am J Prev Med; 2024 Jan; 66(1):10-17. PubMed ID: 37633426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
    Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting.
    McCrae K; Tobias S; Grant C; Lysyshyn M; Laing R; Wood E; Ti L
    Drug Alcohol Rev; 2020 Jan; 39(1):98-102. PubMed ID: 31746056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.